NCT02377843 Making Effective Human Papillomavirus (HPV) Vaccine Recommendations Status COMPLETED Phase NA
NCT02373072 A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of PF-06649751 in Subjects With Idiopathic Parkinson's Disease Status COMPLETED Phase PHASE1
NCT02369653 A Study of the Safety and Effectiveness of Apixaban in Preventing Blood Clots in Children With Leukemia Who Have a Central Venous Catheter and Are Treated With Asparaginase Status COMPLETED Phase PHASE3
NCT02367456 A Combination Study of PF-04449913 (Glasdegib) and Azacitidine In Untreated MDS, AML and CMML Patients Status COMPLETED Phase PHASE1
NCT02366637 An Evaluation Of PF-03715455 In Moderate To Severe Chronic Obstructive Pulmonary Disease Status TERMINATED Phase PHASE2
NCT02364999 A Comparative Study Of PF-06439535 Plus Paclitaxel-Carboplatin And Bevacizumab Plus Paclitaxel-Carboplatin Patients With Advanced Non-Squamous NSCLC Status COMPLETED Phase PHASE3
NCT02364596 Evaluation of a Single Vaccination With a 4-Antigen Staphylococcus Aureus Vaccine (SA4Ag) in Healthy Adults Aged 18 to <65 Years Status COMPLETED Phase PHASE1
NCT02364284 Reporting Patterns and Results of Initial Antibiotic Treatment in Patients With cUTI, cIAI,NP Including VAP Status COMPLETED Phase N/A
NCT02351856 A Rollover Study of ARRY-371797 in Patients With LMNA-Related Dilated Cardiomyopathy Status COMPLETED Phase PHASE2
NCT02349633 Study For Patients With NSCLC EGFR Mutations (Del 19 or L858R +/- T790M) Status TERMINATED Phase PHASE1/PHASE2
NCT02349607 Assessment of the Analgesic Effects of PF-05089771 and Pregabalin in Healthy Volunteers Using Evoked Pain Endpoints Status COMPLETED Phase PHASE1
NCT02346344 Outpatient Characterization of the Variability of Insulin Secretory Parameters in the Meal Tolerance and the Maximal Stimulation Tests of Subjects With Type 2 Diabetes Mellitus Status COMPLETED Phase N/A
NCT02343718 Vinblastine and Temsirolimus in Pediatrics With Recurrent or Refractory Lymphoma or Solid Tumours Including CNS Tumours Status COMPLETED Phase PHASE1
NCT02342548 Open Label Extension Study To Investigate Long Term Safety, Tolerability And Efficacy Of Pf-02545920 In Subjects With Huntington's Disease Who Completed Study A8241021 Status TERMINATED Phase PHASE2
NCT02339818 Evaluation of the Effectiveness of Eliquis ® (Apixaban) Risk Minimization Tools in European Economic Area (EEA) Countries Status COMPLETED Phase N/A
NCT02336178 Safety and Efficacy of Benefix in Patients With Hemophilia B in Usual Care Settings in China Status COMPLETED Phase PHASE4
NCT02334800 A Study To Describe The Effect Of Impaired Hepatic Function Of The Pharmacokinetics Of Palbociclib Status COMPLETED Phase PHASE1
NCT02334527 Phase II Trial of Palbociclib in Patients With Metastatic Urothelial Cancer After Failure of First-Line Chemotherapy Status TERMINATED Phase PHASE2